Form 4 for HCSG HEALTHCARE SERVICES GROUP INC
Accepted 2025-01-06 00:00:00 ET · period of report 2024-12-31 · accession 0000731012-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-06 | 2025-01-04 | HCSG | Orr Patrick J | EVP, Chief Revenue Off | F - Tax | $0.00 | -4,964 | 30.5K | -14% | $0 |
| DM | 2025-01-06 | 2025-01-03+ | HCSG | Orr Patrick J | EVP, Chief Revenue Off | M - OptEx | $0.00 | +11.1K | 27.2K | +69% | $0 |
| D | 2025-01-06 | 2024-12-31 | HCSG | Orr Patrick J | EVP, Chief Revenue Off | A - Grant | $8.81 | +2,408 | 24.4K | +11% | +$21.2K |
| DM | 2025-01-06 | 2024-12-31+ | HCSG | Orr Patrick J | EVP, Chief Revenue Off | A - Grant | $6.02 | +55.1K | 26.0K | New | +$331.7K |
| DM | 2025-01-06 | 2025-01-03+ | HCSG | Orr Patrick J | EVP, Chief Revenue Off | M - OptEx | $0.00 | -11.1K | 23.9K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-04 | F | D | 4,964 | $0.00 | 30,542 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-03 | M | A | 5,970 | $0.00 | 35,506 | D | — | — | |
| 3 | Common | Common Stock | 2025-01-04 | M | A | 2,364 | $0.00 | 29,536 | D | — | — | |
| 4 | Common | Common Stock | 2024-12-31 | A | A | 2,408 | $8.81 | 24,385 | D | — | — | (F1) Acquired by the Reporting Person through participation in the Healthcare Services Group, Inc. Employee Stock Purchase Plan. |
| 5 | Common | Common Stock | 2025-01-03 | M | A | 1,289 | $0.00 | 25,674 | D | — | — | |
| 6 | Common | Common Stock | 2025-01-04 | M | A | 1,498 | $0.00 | 27,172 | D | — | — | |
| 7 | Derivative | Phantom Stock | 2024-12-31 | A | A | 2,266 | $11.62 | 9,423 | D | — · — to — | 2,266 Common Stock | (F3) Shares of Phantom Stock are payable in-kind following termination of the Reporting Person's employment with Issuer. (F4) Acquired pursuant to an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan. (F2) Shares issued at conversion rate of 1-for-1 basis. |
| 8 | Derivative | Restricted Stock Units | 2025-01-03 | M | D | 1,289 | $0.00 | 0 | D | — · — to — | 1,289 Common Stock | (F2) Shares issued at conversion rate of 1-for-1 basis. (F5) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2020 grant date. |
| 9 | Derivative | Restricted Stock Units | 2025-01-04 | M | D | 1,498 | $0.00 | 1,498 | D | — · — to — | 1,498 Common Stock | (F2) Shares issued at conversion rate of 1-for-1 basis. (F6) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2021 grant date. |
| 10 | Derivative | Restricted Stock Units | 2025-01-04 | M | D | 2,364 | $0.00 | 4,726 | D | — · — to — | 2,364 Common Stock | (F2) Shares issued at conversion rate of 1-for-1 basis. (F7) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date. |
| 11 | Derivative | Restricted Stock Units | 2025-01-03 | M | D | 5,970 | $0.00 | 23,881 | D | — · — to — | 5,970 Common Stock | (F2) Shares issued at conversion rate of 1-for-1 basis. (F8) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2024 grant date. |
| 12 | Derivative | Restricted Stock Units | 2025-01-03 | A | A | 26,862 | $0.00 | 26,862 | D | — · — to — | 26,862 Common Stock | (F2) Shares issued at conversion rate of 1-for-1 basis. (F9) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date. |
| 13 | Derivative | Stock Option (right to buy) | 2025-01-03 | A | A | 25,965 | $11.76 | 25,965 | D | $11.76 · — to 2035-01-03 | 25,965 Common Stock | (F10) These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date. |